DEXTROSE INJECTION
Google image searchProduct monograph
Active ingredient
dextrose, 50 %/W/V
DIN: 02517132
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Ethical
Company: OMEGA LABORATORIES LIMITED
Date: 30-MAR-2022
ATC:
- B05 — BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS (ATC, ATC/DDD, )
- B05B — I.V. SOLUTIONS (ATC, ATC/DDD)
- B05BA — Solutions for parenteral nutrition (ATC, ATC/DDD)
- B05BA03 — CARBOHYDRATES (ATC/DDD)
Pharmaceutical standard: USP
